Is Less More? A Microsimulation Model Comparing Cost-effectiveness of the Revised American Thyroid Association's 2015 to 2009 Guidelines for the Management of Patients With Thyroid Nodules and Differentiated Thyroid Cancer
- 1 April 2020
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 271 (4) , 765-773
Abstract
Objective: To assess relative clinical and economic performance of the revised American Thyroid Association (ATA) thyroid cancer guidelines compared to current standard of care. Background: Diagnosis of thyroid cancer in the United States has tripled whereas mortality has only marginally increased. Most patients present with small papillary carcinomas and have historically received at least a total thyroidectomy as a treatment. In 2015, the ATA released the revised guidelines recommending an option for active surveillance (AS) of small papillary thyroid carcinoma and thyroid lobectomy for larger unifocal tumors. Methods: We created a Markov microsimulation model to evaluate the performance of the ATA's 2015 guidelines compared to the ATA's 2009 guidelines. We modeled a cohort of simulated patients with demographic and thyroid nodule characteristics representative of those presenting clinically in the United States. Outcome measures include life expectancy, quality-adjusted life years, costs, and frequency of surgical adverse events. Results: In our base case analysis, the ATA 2015 strategy dominates the ATA 2009 strategy. The ATA 2015 strategy delivers greater discounted average quality-adjusted life years (13.09 vs 12.43) at a lower discounted average cost ($14,752 vs $20,126). Deaths due to thyroid cancer under the 2015 strategy are higher than the 2009 strategy but this is offset by a reduction in surgical deaths, leading to greater average life expectancy under the ATA 2015 strategy. The optimal strategy is sensitive to patients who experience a greater decrement in quality of life while undergoing AS. Conclusions: The ATA 2015 Guidelines represent a cost-effective strategy regarding AS and extent of surgery.Keywords
This publication has 62 references indexed in Scilit:
- Factors Influencing the Outcome of Patients with Incidental Papillary Thyroid MicrocarcinomaJournal of Thyroid Research, 2012
- Thyroidectomy OutcomesOtolaryngology–Head and Neck Surgery, 2012
- Clinical features and prognostic factors in papillary thyroid microcarcinoma depends on ageJournal of the Korean Surgical Society, 2012
- Thyroid hormone replacement after thyroid lobectomySurgery, 2009
- Higher Serum Thyroid Stimulating Hormone Level in Thyroid Nodule Patients Is Associated with Greater Risks of Differentiated Thyroid Cancer and Advanced Tumor StageThe Journal of Clinical Endocrinology & Metabolism, 2008
- Extent of Surgery Affects Survival for Papillary Thyroid CancerAnnals of Surgery, 2007
- Total Thyroidectomy Plus Neck Dissection in Differentiated Papillary Thyroid Carcinoma PatientsAnnals of Surgery, 2007
- Papillary thyroid microcarcinoma (PTMC): Prognostic factors, management and outcome in 403 patientsEuropean Journal of Surgical Oncology, 2006
- Surgery versus medical follow-up in patients with asymptomatic primary hyperparathyroidism: a decision analysisEuropean Journal of Endocrinology, 2005
- Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996Cancer, 2000